BP has shed 6.5% in a week, reversing most of the gain celebrated in last Tuesday's note, and the move is less a BP-specific story than a broad energy sector retreat.
The peer group confirms the sector angle. EQNR fell 6.1% on the week and AKRBP dropped 6.1% in parallel. ENI lost 4.3% and SHEL shed 3.9%. BP's 6.5% decline is fractionally worse than its closest peers, but the direction is shared across the board — this is an energy tape story, not a company-specific one. Only OKEA, which bucked the group with a 0.9% weekly loss, held up meaningfully better.
The lending market offers no explanation for BP's underperformance. The borrow market remains completely unencumbered: availability is at the maximum observable reading, with over 15 billion shares available against negligible demand. Cost to borrow has actually eased 14.5% on the week to 0.56%. The short score of 26.0 ranks in the 92nd percentile for low short pressure across the universe. No short-side conviction is building here — the price weakness is coming from sellers, not from growing short positions. Positioning looks about as loose as it gets.
Valuation has compressed modestly alongside the price decline. The P/E ratio has drifted down by roughly 0.4x over the week to 8.5x, while EV/EBITDA has nudged lower to 3.9x. Both multiples are undemanding by any standard. The dividend factor score ranks in the 97th percentile — near the top of the entire universe — and the trailing dividend yield implied by the data is close to 4.9%. That income support has historically attracted buyers on dips into the mid-500p range, and the stock is now back below that level at 542.3p. The EPS momentum score over 30 days remains solid at the 78th percentile, suggesting estimate revisions have not yet turned negative.
Insider activity is consistent but token in size. On September 10, four executives — including CFO Kate Thomson and EVP Upstream Gordon Birrell — made small open-market purchases at 557.1p. The same cluster bought in August at 517.2p. The amounts are modest (fewer than 75 shares each in the September batch), and the significance ratings are low, so these read more as share-plan participation than high-conviction buying signals. They do, however, confirm that management has been adding at prices above the current level — a mild data point to sit alongside the valuation story.
Q3 results are due October 30. The most recent print in early August produced a sharp one-day decline of 6.7% that recouped only partially over the following five sessions, ending the week down 2.9%. With the stock having now given back the post-Q2 recovery and trading near the lower end of its recent range, the October print is the next genuine inflection point worth watching.
See the live data behind this article on ORTEX.
Open BP. on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
